Clinical Trial Update: Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 study of blinatumomab in children and adolescents with relapsed or refractory B-precursor acute lymphoblastic leukemia; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Amgen Research (Munich) GmbH | Conditions: Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-02-08